Roles of LPA in ovarian cancer development and progression

被引:10
|
作者
Pua, Tarah L. [2 ]
Wang, Feng-qiang
Fishman, David A. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, New York, NY 10029 USA
[2] NYU, Sch Med, New York, NY USA
关键词
LPA; lysophosphatidic acid; ovarian cancer; LYSOPHOSPHATIDIC ACID RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-COUPLED RECEPTOR; LIPID PHOSPHATE PHOSPHATASES; NF-KAPPA-B; PLASMINOGEN-ACTIVATOR EXPRESSION; GYNECOLOGIC-ONCOLOGY-GROUP; INDUCED CELL-MIGRATION; CARCINOMA-CELLS; MATRIX-METALLOPROTEINASE;
D O I
10.2217/FON.09.120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lysophosphatidic acid (LPA), a bioactive phospholipid, stimulates survival, proliferation, adhesion, migration and invasion of ovarian cancer cells through the activation of G-protein-coupled plasma membrane receptors. LPA and its receptors are aberrantly expressed in ovarian cancer, with high levels predominantly found in malignant ascites and in the plasma of ovarian cancer patients. LPA signals multiple intracellular pathways, such as Ras/MEKK1-MAPK and PI3K/Akt, to promote growth factors and protease expression, and induce angiogenesis and tumor cell invasion through the extracellular matrix and across the basement membrane. Only a small portion of this intricate lipid-signaling cascade has been characterized thus far, We believe that elucidation of this complex transduction network will provide further opportunities to understand the mechanism of ovarian carcinogenesis, invasion and metastasis.
引用
收藏
页码:1659 / 1673
页数:15
相关论文
共 50 条
  • [1] Kindlins: Roles in development and cancer progression
    Zhan, Jun
    Zhang, Hongquan
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 98 : 93 - 103
  • [2] The Roles of Glycodelin in Cancer Development and Progression
    Cui, Juan
    Liu, Yanguo
    Wang, Xiuwen
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [3] The biological roles of CD47 in ovarian cancer progression
    Xing, Linan
    Wang, Zhao
    Feng, Yue
    Luo, Haixia
    Dai, Guijiang
    Sang, Lin
    Zhang, Chunlong
    Qian, Jianhua
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (08)
  • [4] Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer
    Wei, Li
    Xue, Tao
    Wang, Jian
    Chen, Biliang
    Lei, Yingfeng
    Huang, Yanhong
    Wang, Hongying
    Xin, Xiaoyan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 791 - 806
  • [5] Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression
    Wei, Jinfen
    Hu, Meiling
    Huang, Kaitang
    Lin, Shudai
    Du, Hongli
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 28
  • [6] Roles of Obesity in the Development and Progression of Breast Cancer
    Reggiani, Francesca
    Bertolini, Francesco
    [J]. DISCOVERY MEDICINE, 2017, 24 (133) : 183 - 190
  • [7] Roles of LPA receptor signaling in breast cancer
    Wang, Jizhao
    Sun, Yuchen
    Qu, Jingkun
    Yan, Yan
    Yang, Ya
    Cai, Hui
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (10) : 1103 - 1111
  • [8] LPA stimulates glycolytic shift in ovarian cancer
    Ha, Ji Hee
    Radhakrishnan, Rangasudhagar
    Ward, Jeremy D.
    Jayaraman, Muralidharan
    Dhanasekaran, Danny N.
    [J]. CANCER RESEARCH, 2017, 77
  • [9] Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
    Al-Hujaily, Ensaf M.
    Tang, Yong
    Yao, De-Sheng
    Carmona, Euridice
    Garson, Kenneth
    Vanderhyden, Barbara C.
    [J]. CANCER PREVENTION RESEARCH, 2015, 8 (12) : 1163 - 1173
  • [10] The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer
    Zhang, Zhen
    Zhao, Hong
    Chu, Chu
    Fu, Xiaoxiao
    Liu, Yonglin
    Wang, Li
    Wei, Ran
    Xu, Ke
    Li, Lihua
    Li, Xia
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13